Literature DB >> 36151376

Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update.

Marcus J C Long1,2, Phillippe Ly3,4, Yimon Aye5,6.   

Abstract

Herein we present a multidisciplinary discussion of ribonucleotide reductase (RNR), the essential enzyme uniquely responsible for conversion of ribonucleotides to deoxyribonucleotides. This chapter primarily presents an overview of this multifaceted and complex enzyme, covering RNR's role in enzymology, biochemistry, medicinal chemistry, and cell biology. It further focuses on RNR from mammals, whose interesting and often conflicting roles in health and disease are coming more into focus. We present pitfalls that we think have not always been dealt with by researchers in each area and further seek to unite some of the field-specific observations surrounding this enzyme. Our work is thus not intended to cover any one topic in extreme detail, but rather give what we consider to be the necessary broad grounding to understand this critical enzyme holistically. Although this is an approach we have advocated in many different areas of scientific research, there is arguably no other single enzyme that embodies the need for such broad study than RNR. Thus, we submit that RNR itself is a paradigm of interdisciplinary research that is of interest from the perspective of the generalist and the specialist alike. We hope that the discussions herein will thus be helpful to not only those wanting to tackle RNR-specific problems, but also those working on similar interdisciplinary projects centering around other enzymes.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  DNA replication and repair; Deoxynucleotide pools; Genome maintenance; Moonlighting functions; Ribonucleotide reductases

Mesh:

Substances:

Year:  2022        PMID: 36151376     DOI: 10.1007/978-3-031-00793-4_5

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  165 in total

1.  Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.

Authors:  Md Faiz Ahmad; Sarah E Huff; John Pink; Intekhab Alam; Andrew Zhang; Kay Perry; Michael E Harris; Tessianna Misko; Suheel K Porwal; Nancy L Oleinick; Masaru Miyagi; Rajesh Viswanathan; Chris Godfrey Dealwis
Journal:  J Med Chem       Date:  2015-12-09       Impact factor: 7.446

2.  In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes.

Authors:  Nilüfer Aydemir; Serap Celikler; Rahmi Bilaloğlu
Journal:  Mutat Res       Date:  2005-04-04       Impact factor: 2.433

3.  Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule.

Authors:  Md Faiz Ahmad; Intekhab Alam; Sarah E Huff; John Pink; Sheryl A Flanagan; Donna Shewach; Tessianna A Misko; Nancy L Oleinick; William E Harte; Rajesh Viswanathan; Michael E Harris; Chris Godfrey Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

4.  Enzyme regulation. IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes.

Authors:  Alexei Arnaoutov; Mary Dasso
Journal:  Science       Date:  2014-09-19       Impact factor: 47.728

Review 5.  Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.

Authors:  Y Aye; M Li; M J C Long; R S Weiss
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

6.  p53 directs focused genomic responses in Drosophila.

Authors:  F Akdemir; A Christich; N Sogame; J Chapo; J M Abrams
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

7.  Clofarabine targets the large subunit (α) of human ribonucleotide reductase in live cells by assembly into persistent hexamers.

Authors:  Yimon Aye; Edward J Brignole; Marcus J C Long; Johnathan Chittuluru; Catherine L Drennan; Francisco J Asturias; JoAnne Stubbe
Journal:  Chem Biol       Date:  2012-07-27

8.  Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.

Authors:  H Akita; Z Zheng; Y Takeda; C Kim; N Kittaka; S Kobayashi; S Marubashi; I Takemasa; H Nagano; K Dono; S Nakamori; M Monden; M Mori; Y Doki; G Bepler
Journal:  Oncogene       Date:  2009-06-22       Impact factor: 9.867

9.  Allosteric Inhibition of Human Ribonucleotide Reductase by dATP Entails the Stabilization of a Hexamer.

Authors:  Nozomi Ando; Haoran Li; Edward J Brignole; Samuel Thompson; Martin I McLaughlin; Julia E Page; Francisco J Asturias; JoAnne Stubbe; Catherine L Drennan
Journal:  Biochemistry       Date:  2016-01-04       Impact factor: 3.162

10.  IRBIT Directs Differentiation of Intestinal Stem Cell Progeny to Maintain Tissue Homeostasis.

Authors:  Alexei Arnaoutov; Hangnoh Lee; Karen Plevock Haase; Vasilisa Aksenova; Michal Jarnik; Brian Oliver; Mihaela Serpe; Mary Dasso
Journal:  iScience       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.